by Jordana Choucair | May 11, 2022 | Opioid/Substance Use Disorders
Join Third Horizon Strategies Managing Director Greg Williams on June 7 for a Tech Talk examining tech requirements for value-based care for behavioral health and substance use disorder (SUD) providers. Greg and Hans Morefield, CEO of CHESS Health, will discuss...
by Jordana Choucair | May 10, 2022 | Opioid/Substance Use Disorders
A federal judge in Cleveland will begin hearing testimony today to determine how much three pharmacy chains should pay two Ohio counties in damages to help abate the effects of the opioid crisis. Last fall, a jury found that the way CVS, Walgreens, and Walmart...
by Jordana Choucair | May 6, 2022 | Opioid/Substance Use Disorders
Walgreens reached a $683 million settlement with the state of Florida to resolve claims that the company improperly dispensed millions of opioid pills. Lawyers for Florida said Walgreens dispensed more than 4.3 billion opioid pills in Florida over a 15-year period and...
by Jordana Choucair | May 3, 2022 | Opioid/Substance Use Disorders
Two Representatives sent a letter warning Attorney General Merrick Garland that the deals Teva Pharmaceuticals struck with Texas, Florida, and Rhode Island could create shortages of treatment and opioid reversal drugs in the rest of the country. “These...
by Jordana Choucair | Apr 28, 2022 | Opioid/Substance Use Disorders
Members of the House Oversight and Reform Committee questioned McKinsey & Company about its potential role in exacerbating the opioid epidemic. The hearing comes after the committee released a report alleging a years-long conflict of interest stemming from...
by Jordana Choucair | Apr 21, 2022 | Opioid/Substance Use Disorders
The White House is set to unveil President Joe Biden’s first National Drug Control Strategy today. The director of the White House Office of National Drug Control Policy, Dr. Rahul Gupta, said that the document prioritizes harm reduction, access to substance use...
Recent Comments